KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Non-cash Items (2017 - 2018)

Historic Non-cash Items for Alnylam Pharmaceuticals (ALNY) over the last 9 years, with Q4 2018 value amounting to $5.7 million.

  • Alnylam Pharmaceuticals' Non-cash Items rose 831.13% to $5.7 million in Q4 2018 from the same period last year, while for Dec 2018 it was $5.7 million, marking a year-over-year increase of 831.13%. This contributed to the annual value of $5.7 million for FY2018, which is 831.13% up from last year.
  • Per Alnylam Pharmaceuticals' latest filing, its Non-cash Items stood at $5.7 million for Q4 2018, which was up 831.13% from $5.3 million recorded in Q4 2017.
  • Alnylam Pharmaceuticals' Non-cash Items' 5-year high stood at $5.7 million during Q4 2018, with a 5-year trough of $4.7 million in Q4 2015.
  • In the last 4 years, Alnylam Pharmaceuticals' Non-cash Items had a median value of $5.0 million in 2014 and averaged $5.1 million.
  • As far as peak fluctuations go, Alnylam Pharmaceuticals' Non-cash Items tumbled by 9864.25% in 2014, and later skyrocketed by 831.13% in 2018.
  • Over the past 4 years, Alnylam Pharmaceuticals' Non-cash Items (Quarter) stood at $4.7 million in 2014, then fell by 0.78% to $4.7 million in 2015, then rose by 12.66% to $5.3 million in 2017, then increased by 8.31% to $5.7 million in 2018.
  • Its Non-cash Items stands at $5.7 million for Q4 2018, versus $5.3 million for Q4 2017 and $4.7 million for Q4 2015.